Takeaways

#
  • Gatlin used an adverse biotech outcome to explain why conviction did not replace position sizing.
  • The hosts connected metals strength to the dollar’s failed breakout, while distinguishing MT’s completed reversal from GGB’s remaining resistance.
  • Boston Scientific’s longer-term recovery idea and Zoetis’s relative weakness produced different healthcare assessments.
  • American Eagle’s tactical base and Prosperity Bankshares’ unfinished breakout required attention to time frame and confirmation.

Sam Gatlin began the August 10, 2026 Chart Request Live with a position that had gone badly wrong. A biotech chart he had liked, backed by a story he had believed in, had fallen sharply after a clinical readout. His response was to revisit position sizing. Confidence in a setup had not made the outcome certain.

That admission mattered to the chart review that followed. The hosts were constructive on several metals and healthcare stocks, but their enthusiasm came with distinctions about confirmation, time frame and risk. Some charts had already broken out. Others still needed to prove they could get through resistance.

Position size came before conviction

Gatlin described sizing biotechnology exposure with the possibility of a total loss in mind. His co-host agreed that he used smaller positions in biotech because of the risks involved. Neither presented a good-looking chart as protection against an adverse result.

The discussion later returned to biotechnology with Vertex Pharmaceuticals, VRTX. The hosts liked its emergence from a prolonged base and the gap higher they were observing that day. Their positive view of Vertex did not erase the opening lesson. The two discussions showed why a favorable price pattern and the amount committed to it remained separate decisions.

A weaker dollar supported the metals discussion

The hosts linked renewed interest in metals to the dollar’s failed breakout and return to its prior range. They viewed additional dollar weakness as a condition that could support the metals trade. That was their reading of the August 10 environment, with the currency’s next move still unresolved.

Two steel requests illustrated different stages of progress. MT had cleared a shelf of resistance and was advancing from its base. The hosts treated that reversal as complete, while watching the area below it for support.

GGB had reclaimed an anchored volume-weighted average price measured from its all-time high. They considered that constructive, but identified another boundary at the top of its base that still needed to clear. The sector backdrop could strengthen the case for watching GGB; it could not complete the remaining breakout for it.

Healthcare required more than a sector label

Boston Scientific, BSX, arrived in the mailbag as a question about long-dated calls. The hosts could see the support area the viewer was using, yet they also stressed how much repair the downtrend required. A longer option term gave the idea more time, without turning the chart into an established uptrend.

Gatlin then raised the possibility that medical devices could benefit from the rotation he was seeing into software. He compared the historical behavior of the two groups. That was a reason to investigate a potential catch-up move, rather than evidence that it had already happened.

Zoetis, ZTS, received a much less favorable assessment. Its relative weakness against healthcare mattered as much as the attempt to stop falling. The hosts wanted a recovery above resistance before reconsidering it from the long side. A healthcare theme alone did not make every healthcare stock attractive to them.

Time frame changed what a chart could offer

American Eagle, AEO, made the time-frame distinction explicit. The hosts saw a possible short-term base within a much larger sideways range. A move toward the top of that range could be relevant to a tactical trade, while the longer chart still lacked sustained progress.

Prosperity Bankshares, PB, offered another unfinished setup. Regional-bank strength encouraged them, and the chart was approaching the upper part of its range. They nevertheless preferred to wait for a breakout, noting earlier failed attempts.

That patience also shaped the Bitcoin and Ethereum discussion. The hosts wanted stronger evidence of a reversal and saw more appealing opportunities in software at the time.

Across these requests, the August 10 episode kept two questions in view: what had price actually confirmed, and how much risk did the idea deserve? Gatlin’s opening biotech experience gave the second question weight. The later charts supplied examples of why the first answer could differ even among stocks in the same broad theme.

Questions and answers

#

Questions answered in the original 2026-08-10 episode.

What risk lesson opened the August 10 episode?

Sam Gatlin described a biotech position falling sharply after a clinical readout despite his earlier conviction. He and his co-host emphasized smaller position sizing to account for that kind of uncertainty.

Link to this answer

Why were the hosts interested in metals?

They connected metals rotation to a failed dollar breakout and the dollar’s return to its prior range. MT and GGB supplied steel examples, although the hosts saw them at different stages of breakout confirmation.

Link to this answer

Did the hosts treat every healthcare recovery as equally attractive?

No. They discussed the time needed for Boston Scientific to repair its downtrend, highlighted Zoetis’s relative weakness and welcomed Vertex’s observed base breakout. Those were separate chart assessments.

Link to this answer

Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .